Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. The company employs 24,379 full-time employees. The company went IPO on 2003-12-08. The firm operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long-term and short-term investments. The Other segment is principally engaged in the related medical and hospital business.
Follow-Up Questions
Who is the CEO of Sino Biopharmaceutical Ltd?
Mr. S. Y. Tse is the Chief Executive Officer of Sino Biopharmaceutical Ltd, joining the firm since 2019.
What is the price performance of SBHMY stock?
The current price of SBHMY is $20.16, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Sino Biopharmaceutical Ltd?
Sino Biopharmaceutical Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Sino Biopharmaceutical Ltd market cap?
Sino Biopharmaceutical Ltd's current market cap is $18.0B
Is Sino Biopharmaceutical Ltd a buy, sell, or hold?
According to wall street analysts, 26 analysts have made analyst ratings for Sino Biopharmaceutical Ltd, including 10 strong buy, 18 buy, 2 hold, 0 sell, and 10 strong sell
